Although these results should be taken with caution because of the limitations of this study (low overall rate of events, short duration of treatment period, events not assessed by an ophthalmologist), this clinical data suggests that inhibition of IL-17A and IL-17F may be effective for the prevention of non-infectious anterior uveitis in this scenario (14). The gene discussed is IL17A; the disease is anterior uveitis.